Marinus Pharmaceuticals, Inc.
MRNSDelisted Feb 11, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001267813
Marinus Pharmaceuticals, Inc. was delisted on Feb 11, 2025; its insiders filed their last Form 4 on Feb 11, 2025; 53 institutions reported holding it in 13F filings for Q4 2024, worth $15.8M in total; no superinvestor held it.
13F holders, Q1 2025
Institutional positions in Marinus Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
MRNS is no longer listed, and 13F filings after Q4 2024 list far fewer holders. See Q4 2024
- Institutional holders
- 0
- −53 vs. Q4 2024
- Shares held
- 0
- −29.6M (−100.0%) vs. Q4 2024
- Total value
- $0
- −$15.8M (−100.0%) vs. Q4 2024
- New holders
- 0
- 0 more added
- Sold out
- 53
- 0 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MRNS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 53 | $15.8M |
| Q3 2024 | 75 | $72.9M |
| Q2 2024 | 90 | $50.6M |
| Q1 2024 | 112 | $486.5M |
| Q4 2023 | 105 | $585.2M |
| Q3 2023 | 104 | $411.1M |
| Q2 2023 | 106 | $485.0M |
| Q1 2023 | 86 | $283.9M |
| Q4 2022 | 74 | $165.6M |
| Q3 2022 | 69 | $186.9M |
| Q2 2022 | 73 | $140.6M |
| Q1 2022 | 83 | $280.4M |
| Q4 2021 | 75 | $355.7M |
| Q3 2021 | 82 | $362.0M |
| Q2 2021 | 80 | $563.3M |
| Q1 2021 | 87 | $480.3M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Marinus Pharmaceuticals, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Beryl Capital Management LLC | 0 | $0 | 0.00% | −4,227,460−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −3,299,229−100.0% | Sold out |
| Oddo BHF Asset Management SAS | 0 | $0 | 0.00% | −2,700,000−100.0% | Sold out |
| Bain Capital Life Sciences Investors, LLC | 0 | $0 | 0.00% | −2,693,380−100.0% | Sold out |
| Standard Life Aberdeen plc | 0 | $0 | 0.00% | −2,658,527−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −2,596,768−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −2,335,681−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −1,837,491−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −1,641,945−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −883,675−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −696,740−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −529,053−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −501,911−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −487,584−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −290,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −258,944−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −249,138−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −239,414−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −222,576−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −219,819−100.0% | Sold out |
| Deltec Asset Management LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −113,280−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −100,853−100.0% | Sold out |
| Gabelli & Co Investment Advisers, Inc. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −66,717−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −57,128−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −52,328−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −44,200−100.0% | Sold out |
| Harvest Investment Services, LLC | 0 | $0 | 0.00% | −41,144−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −30,943−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −23,199−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −22,868−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −20,779−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −20,356−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −16,023−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −12,518−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −12,897−100.0% | Sold out |
| Perfromance Wealth Partners, LLC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −9,526−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −6,310−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −6,001−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −2,286−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −1,800−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −1,653−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −1,322−100.0% | Sold out |
| 1620 Investment Advisors, Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −932−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −275−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −115−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −54−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −3,092−100.0% | Sold out |